Mckesson Medical-Surgical Inc. Corporate Office recalls Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MFG
Recalled June 15, 2022 · FDA recall D-1083-2022 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP deviations: Temperature abuse · FDA Class II
Units
56 cartons/10 patches each
Sold at
USA nationwide.
Description
cGMP deviations: Temperature abuse
Product
Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MFG: Baxter Healthcare Corp, NDC 10019-553-03
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →